Generation of site-specific DARPin® drug conjugates using EGFR as a model system

被引：0

作者：

Laviolette, Laura A. ^{[1
]}

Guidi, Cynthia J. ^{[1
]}

Reichen, Christian ^{[2
]}

Qiu, Qifeng ^{[1
]}

Harris, Luke ^{[1
]}

Schildknecht, Patricia ^{[2
]}

Fischer, Stefanie ^{[2
]}

Arany, Zita ^{[2
]}

Hospodarsch, Tanja ^{[2
]}

Skaletskaya, Anna ^{[1
]}

Fuller, Megan ^{[1
]}

Abbott, Stephen ^{[1
]}

McCarthy, Rebecca ^{[1
]}

Lee, Jenny ^{[1
]}

Francisco, Katherine ^{[1
]}

Sinkevicius, Kerstin ^{[1
]}

Adams, Sharlene ^{[1
]}

Espelin, Christopher ^{[1
]}

Reid, Emily ^{[1
]}

Li, Wei ^{[1
]}

Marashio, Carla ^{[1
]}

Donahue, Kerry ^{[1
]}

Hicks, Stuart ^{[1
]}

Snell, Dan ^{[2
]}

机构：

[1] ImmunoGen Inc, Waltham, MA USA

[2] Mol Partners AG, Zurich, Switzerland

来源：

CANCER RESEARCH | 2019年 / 79卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2019-215

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

215

引用

页数：2

共 50 条

[31] AJICAP™: Development of a Chemical Site-Specific Conjugation Technology for Antibody-Drug Conjugates
Yamada, Kei
Okuzumi, Tatsuya
JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 2020, 78 (05) : 495 - 502
[32] Site-specific antibody-drug conjugates via a trapped-Knoevenagel ligation
Kudirka, Romas
Barfield, Robyn M.
McFarland, Jesse M.
Albers, Aaron E.
Dehart, Gregory W.
Drake, Penelope M.
Jones, Lesley C.
Holder, Patrick G.
Garafalo, Albert W.
Zmolek, Wes
Banas, Stefanie
Rabuka, David
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
[33] Tumor Site-Specific Cleavage Improves the Antitumor Efficacy of Antibody-Drug Conjugates
Xu, Keyuan
Han, Jiani
Yang, Liu
Cao, Li
Li, Shuang
Hong, Zhangyong
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (13)
[34] An Integrated In Vivo/In Vitro Protein Production Platform for Site-Specific Antibody Drug Conjugates
Hanson, Jeffrey
Groff, Dan
Carlos, Abi
Usman, Hans
Fong, Kevin
Yu, Abigail
Armstrong, Stephanie
Dwyer, Allison
Masikat, Mary Rose
Yuan, Dawei
Tran, Cuong
Heibeck, Tyler
Zawada, James
Chen, Rishard
Hallam, Trevor
Yin, Gang
BIOENGINEERING-BASEL, 2023, 10 (03):
[35] Selective Reduction of Cysteine Mutant Antibodies for Site-Specific Antibody-Drug Conjugates
Liao, Xiaoli
Haight, Anthony
Welch, Dennie
Han, Linjie
BIOCONJUGATE CHEMISTRY, 2023, 34 (12) : 2293 - 2301
[36] Synthesis of site-specific antibody-drug conjugates by ADP-ribosyl cyclases
Dai, Zhefu
Zhang, Xiao-Nan
Nasertorabi, Fariborz
Cheng, Qinqin
Li, Jiawei
Katz, Benjamin B.
Smbatyan, Goar
Pei, Hua
Louie, Stan G.
Lenz, Heinz-Josef
Stevens, Raymond C.
Zhang, Yong
SCIENCE ADVANCES, 2020, 6 (23):
[37] Mass Spectrometric Characterization of Transglutaminase Based Site-Specific Antibody-Drug Conjugates
Farias, Santiago E.
Strop, Pavel
Delaria, Kathy
Casas, Meritxell Galindo
Dorywalska, Magdalena
Shelton, David L.
Pons, Jaume
Rajpal, Arvind
BIOCONJUGATE CHEMISTRY, 2014, 25 (02) : 240 - 250
[38] Chemoenzymatic glycan labelling as a platform for site-specific IgM-antibody drug conjugates
Moh, Edward S. X.
Sayyadi, Nima
Packer, Nicolle H.
ANALYTICAL BIOCHEMISTRY, 2019, 584
[39] Cysteine mutant location affects chemotype lability in site-specific antibody drug conjugates
Waight, Andrew
Leiske, Chris
Biechele, Travis
Burke, Patrick
Rohm, Rory
Senter, Peter
Benjamin, Dennis
Sussman, Django
CANCER RESEARCH, 2017, 77
[40] Site-Specific Antibody-Drug Conjugates: The Nexus of Biciorthogonal Chemistry, Protein Engineering, and Drug Development
Agarwal, Paresh
Bertozzi, Carolyn R.
BIOCONJUGATE CHEMISTRY, 2015, 26 (02) : 176 - 192

← 1 2 3 4 5 →